Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis

Fig. 3

Effect of NKILA downregulation on cell characteristics. Invasion (A), proliferation (B), cell cycle (C) and colony forming ability (D) was assessed in parental and cisplatin resistant ES2 cells. The presented results are representative of at least 3 different repeats with triplicate samples in each repeat. NS: non-significant results

Back to article page